Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), bought 12,200 shares at $40.77 ($497K) on 2017-01-31, disclosed to the SEC on 2017-02-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $108K | — | Filing → |
| ABT | SELL | 2018-02-21 | $289K | — | Filing → |